Clinical Features of Patients with Ebola Virus Disease in Sierra Leone

Clinical Infectious Diseases

Volumn 61, Issue 4, 2015, Pages 491-495

  Qin, Enqiang ^a   Bi, Jingfeng ^a   Zhao, Min ^a   Wang, Ye ^a   Guo, Tongsheng ^a   Yan, Tao ^a   Li, Zhiwei ^a   Sun, Juan ^a   Zhang, Jieli ^a   Chen, Suhong ^a   Wu, Yao ^a   Li, Jin ^a   Zhong, Yanwei ^a  

^a Medical Team of Assistance to Sierra Leone   (China)

Author keywords

clinical features; Ebola virus disease; Sierra Leone

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; CLINICAL FEATURE; CLINICAL STUDY; DIARRHEA; DISEASE DURATION; DYSPNEA; EBOLA VIRUS DISEASE; FATIGUE; FEMALE; FEVER; GROUPS BY AGE; HEADACHE; HUMAN; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MORTALITY; MYALGIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIERRA LEONE; SORE THROAT; SURVIVOR; VIRUS INFECTION; VOMITING; WEAKNESS; YOUNG ADULT; AGE; HEMORRHAGIC FEVER, EBOLA; INFANT; PATHOLOGY; PRESCHOOL CHILD; SEX DIFFERENCE; SURVIVAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDIES; SEX FACTORS; SIERRA LEONE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84938576932     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ319     Document Type: Article

References (23)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-25.
2. World Health Organization. Ebola virus disease fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs103/en. Accessed 8 May 2015.
3. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377:849-62.
4. Goeijenbier M, Van Kampen JJ, Reusken CB, et al. Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis. Neth J Med 2014; 72:442-8.
5. World Health Organization. 2014 Ebola outbreak in West Africa-case counts. Available at: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/index.html. Accessed 8 May 2015.
6. World Health Organization. Epicurve by week of onset, Guinea, Liberia and Sierra Leone. Ebola virus disease inWest Africa. Available at: http://apps.who,int/iris/bitstream/10665/144505/1/EVD-20141123.pdf. Accessed 8 May 2015.
7. Centers for Disease Control and Prevention. Update: Ebola virus disease epidemic-West Africa, November 2014. MMWR Morb Mortal Wkly Rep 2014; 63:1064-6.
8. World Health Organization. Case definition recommendations for Ebola or Marburg virus diseases. Available at: http://www.who.int/csr/resources/publications/ebola/ebola-case-definition-contact-en.pdf? ua=1. Accessed 8 May 2015.
9. World Health Organization, Centers for Disease Control and Prevention. Infection control for viral haemorrhagic fevers in the African health care setting. Available at: http://www.cdc.gov/vhf/abroad/pdf/african-healthcare-setting-vhf.pdf. Accessed 8 May 2015.
10. Lee JE, Fusco ML, Hessell AJ, et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008; 454:177-82.
11. Cook JD, Lee JE. The secret life of viral entry glycoproteins: moonlighting in immune evasion. PLoS Pathog 2013; 9:392-4.
12. Francica JR, Varela-Rohena A, Medvec A, et al. Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLoS Pathog 2010; 6:8871-87.
13. Reynard O, Borowiak M, Volchkova VA, et al. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 2009; 83:9596-601.
14. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011; 204(suppl 3): S810-6.
15. Casillas AM, Nyamathi AM, Sosa A, et al. A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs 2003; 4:268-75.
16. Koch S, Larbi A, Derhovanessian E, et al. Multiparameter flow cytometric analysis of CD4 and CD8T cell subsets in young and old people. Immun Ageing 2008; 5:6.
17. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371: 2092-100.
18. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015; 372:40-7.
19. Colebunders R, Tshomba A, Maria D, et al. Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis 2007; 196(suppl 2): S148-53.
20. Borchert M, Mutyaba I, Van Kerkhove MD, et al. Ebola haemorrhagic fever out-break in Masindi District, Uganda: out-break description and lessons learned. BMC Infect Dis 2011; 11:357.
21. Oddy P, Howard N, Van Kerkhove MD, et al. Clinical manifestations and casemanagement of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One 2012; 7:e52986.
22. Smith DH, Johnson BK, Isaacson M, et al. Marburg virus disease in Kenya. Lancet 1982; 1:816-20.
23. World Health Organization Ebola Response Team. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371:1481-96.